Funding and financial support

The Bradley Group would like to recognise the following research partners for their funding and financial support of our work.


ERC Advanced Grant

BBSRC

BHF

Rosetrees Trust

CDT-Optima

EPSRC

FRA

MarieCurie

MRS

MRC

Novartis

Proteus

7

UoE

Wellcometrust

IMPACT

Further information on our research funding can be found below and via this page.

ADREEM: Adding Another Dimension - Arrays of 3D Bio-Responsive materials
Bradley, M.
1/11/14 > 30/09/15
£1,711,766, EU government bodies

Smart materials for targeted stem cell fate and function in skeletal repair
Bradley, M.
31/03/14 > 30/03/17
£374,075, BBSRC

HumEn Project (RTD)
Bickmore, W. & Bradley, M.
1/01/14 > 31/12/17
£828,061, EU government bodies

IMAGFIB: Imaging Fibrosis - Chemistry and Optical Confocal Laser Endomicroscopy
Bradley, M.
1/10/13 > 30/09/15
£171,321, EU government bodies

Multiplexed 'Touch and Tell' Optical Molecular Sensing and Imaging
Bradley, M., Henderson, R., Dhaliwal, K., Haslett, C. & Williams, C.
1/10/13 > 30/09/18
£5,271,731, EPSRC

CLEDEPOLY: Tissue Specific Delivery via Cleavable and Degradable Polymers
Bradley, M.
1/07/13 > 30/06/15
£164,153, EU government bodies

Implantable Microsystems for Personalised Anti-Cancer Therapy
Murray, A., Walton, A., Bradley, M., Argyle, D., Smith, S., Tait, J. & Haddow, G.
27/05/13 > 26/05/18
£2,391,469, EPSRC

A new paradigm for testing pathway tractability in lung disease
Hirani, N., Dhaliwal, K., Haslett, C. & Bradley, M.
1/05/13 > 30/04/16
£295,453, MRC

Chemical Strategies for Epigenome wide discrimination of 5-hydroxymethylcytosine and 5-methylcytosine
Bradley, M. & De Sousa, P.
1/11/12 > 31/10/15
£662,136, EPSRC

Molecular Optical Imaging of Key Targets in the Fibrogenic Pathway in Man
Bradley, M., Dhaliwal, K., Haslett, C., Hirani, N. & McGorum, B.
1/09/12 > 31/12/15
£971,797, MRC